Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
NCT06135870 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-12-11
Summary
The investigators are evaluating the role of senescent cells in uterine fibroids.
Conditions
- Fibroid
- Leiomyoma
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH - lead OTHER
Principal Investigators
-
James Segars, MD · Johns Hopkins University
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
NCT01567046 ·Status: COMPLETED
-
Molecular Mechanism Study of Uterine Sarcoma
NCT05881967 ·Status: RECRUITING
-
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
NCT06689956 ·Status: RECRUITING
-
Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma
NCT01585376 ·Status: COMPLETED
-
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
NCT00579566 ·Status: RECRUITING
-
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
NCT00250783 ·Status: COMPLETED
-
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573 ·Status: UNKNOWN
-
SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer
NCT00900042 ·Status: COMPLETED
-
SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53-Mutated Endometrial Cancer: A Non-Inferiority Randomized Trial
NCT06900582 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
NCT02664883 ·Status: ACTIVE_NOT_RECRUITING
-
Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma
NCT01358617 ·Status: COMPLETED
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
NCT06482957 ·Status: RECRUITING
-
Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer
NCT02499458 ·Status: COMPLETED
-
Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics
NCT06083779 ·Status: UNKNOWN
-
Cytogenetic and Molecular Genetic Studies in Bone Sarcomas
NCT00579930 ·Status: COMPLETED
-
Studies of Neurological Paraneoplastic Syndromes
NCT00587106 ·Status: COMPLETED
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450448 ·Status: COMPLETED
-
Evaluation of ClearLLab LS Screening Panel
NCT05819762 ·Status: COMPLETED
-
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
NCT00582647 ·Status: ACTIVE_NOT_RECRUITING
-
Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors
NCT00580463 ·Status: COMPLETED
-
Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
NCT00095589 ·Status: COMPLETED
-
Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
NCT00582387 ·Status: COMPLETED
-
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861 ·Status: COMPLETED
-
Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
NCT06656949 ·Status: RECRUITING ·Phase: NA